Biosensors & POCT– category –
-
Biosensors & POCT
ASCO Annual Meeting 2026 Signals New Era in Lung Cancer Treatment: Adjuvant Targeted Therapy and ADCs Reshape Immunotherapy Strategies
Targeted Oncology USA Overview Targeted Oncology reports that three key lung cancer abstracts from the ASCO 2026 Annual Meeting could significantly alter clinical practice. These presentations highlight advances in adjuvant targeted ther... -
Biosensors & POCT
CNET Names Dexcom Stelo, Abbott FreeStyle Libre 3 Plus, and Eversense 365 as Top Continuous Glucose Monitors for 2026, Setting New Standards in Blood Sugar Management
CNET USA Overview CNET's 2026 review identifies Dexcom Stelo, Abbott FreeStyle Libre 3 Plus, and Eversense 365 as leading continuous glucose monitoring (CGM) devices. These systems excel in sensor life, accuracy, and FDA approval status,... -
Biosensors & POCT
UTMB Researchers Secure USDA Funding for AI-Enabled Nanobody Biosensor for Rapid Screwworm Detection, Achieving 15-Minute Field Results
The University of Texas Medical Branch USA Overview Researchers at the University of Texas Medical Branch (UTMB) have received USDA funding to develop an AI-enabled rapid detection system for screwworm, safeguarding Texas livestock and w... -
Biosensors & POCT
ASCO Breakthrough 2026 Unveils Over 300 Abstracts Highlighting Advances in Liquid Biopsy, Metabolic Risks, and Tailored Cancer Therapies for Asian Populations
American Society of Clinical Oncology (ASCO) / The ASCO Post USA Overview The American Society of Clinical Oncology (ASCO) has publicly released over 300 abstracts for its 2026 Breakthrough meeting in Singapore and online. The conference... -
Biosensors & POCT
Nanotechnology-Mediated Precision mRNA Delivery Revolutionizes Vaccines and Gene Therapies by Minimizing Off-Target Effects and Maximizing Efficiency
Nature Materials International Overview A Nature Materials review highlights advanced strategies for precision mRNA delivery to cells and tissues, aiming to minimize off-targeting and maximize efficiency. This technology is critical for ... -
Biosensors & POCT
Coherent 2D–3D van der Waals Perovskite Heterostructures Achieved with Atomically Sharp Interfaces and Gate-Tunable Rectification for Advanced Sensors
Nature Nanotechnology International Overview Research in Nature Nanotechnology details the successful growth of coherent 2D–3D van der Waals perovskite heterostructures via cross-dimensional epitaxy, yielding atomically sharp interfaces ... -
Biosensors & POCT
AI-Guided Microrobots Achieve Spatiotemporally Controlled Intracavitary Drug Release, Dramatically Enhancing Bladder Tumor Therapy in Murine Models
Nature Nanotechnology International Overview A breakthrough in Nature Nanotechnology introduces a deep learning-guided image-feedback system enabling non-invasive, real-time navigation and spatiotemporally controlled drug release from ma... -
Biosensors & POCT
Biosensors & POCT Weekly Report May 20, 2026
▼ ▼ ▼ If you found the infographic compelling and want to read the full Weekly Report, click below to download the Strategy Report. ▼ ▼ ▼ 📄 Biosensors & POCT Weekly Report — June 20, 2026 Biosensors_WeeklyReport_EN_20260620.pdfDownload ... -
Biosensors & POCT
Health Outcomes Data from Wearables Pivotal for Medicare Coverage Expansion
Forbes USA Overview Health outcomes data derived from wearable devices are proving crucial for expanding Medicare coverage in the United States. Researchers are actively studying the clinical and cost-effectiveness of various wearable te... -
Biosensors & POCT
SEMI Smart MedTech Initiative Identifies Key Obstacles and Opportunities for Scaling Wearable Biosensors into Clinical Use
SEMI USA Overview The SEMI Smart MedTech Initiative has published a paper detailing the challenges and opportunities in scaling wearable biosensors from wellness tracking to clinical applications. Despite advancements in semiconductor te...